The majority of patients with ABC have estrogen receptor-positive (ER +) and human epidermal growth factor receptor 2-negative (HER2 −) disease with a relatively indolent course, which is commonly treated with endocrine therapies2–4. This evidence concerns the gene ERBB2 and aneurysmal bone cyst.